Palisade Bio (PALI) Prepaid Assets (2010 - 2026)
Palisade Bio (PALI) reported Prepaid Assets of $265000.0 for Q1 2026, down 59.67% year-over-year from $657000.0 in Q1 2025, and down 25.35% quarter-over-quarter from $355000.0 in Q4 2025.
Palisade Bio (PALI) Prepaid Assets (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Prepaid Assets data on file, last reported at $265000.0 in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $265000.0, down 59.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $265000.0 (down 59.67% YoY), and the FY2025 annual result was $355000.0, up 1988.24% from the prior year.
- Prepaid Assets slipped to $265000.0 in Q1 2026 per PALI's latest filing, from $355000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $2.4 million in Q2 2022 and troughed at $4000.0 in Q2 2023.
- A 5-year average of $644588.2 and a median of $531000.0 in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets plunged 99.84% in 2023, then surged 14250.0% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $6000.0 in 2022, then changed by 0.0% to $6000.0 in 2023, then soared by 183.33% to $17000.0 in 2024, then soared by 1988.24% to $355000.0 in 2025, then dropped by 25.35% to $265000.0 in 2026.
- Business Quant data shows PALI's Prepaid Assets at $265000.0 in Q1 2026, $355000.0 in Q4 2025, and $445000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 265,000.00 |
| Dec 31, 2025 | 355,000.00 |
| Sep 30, 2025 | 445,000.00 |
| Jun 30, 2025 | 531,000.00 |
| Mar 31, 2025 | 657,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | 830,000.00 |
| Jun 30, 2024 | 574,000.00 |
| Mar 31, 2024 | 737,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 954,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 355,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 2.44 Mn |
| Mar 31, 2022 | 1.61 Mn |
| Dec 31, 2021 | 540,000.00 |
| Sep 30, 2021 | 1.99 Mn |
| Jun 30, 2021 | 2.01 Mn |